ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 700430 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 700430; 2) Community: the network communities that were significantly associated with the response to NSC 700430; 3) Molecule: the relationships between components within communities and NSC 700430; 4) MDR: the compounds that were significantly associated with the NSC 700430.

NSC Compound Enrichment Correlation
NSC 717571 Null 0.0295480456086947 0.21999465
NSC 736065 2-(4-Trifluoromethoxy-benzenesulfonylimino)-imidazolidine-1- carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester 0.0295480456086947 0.20026278
NSC 736104 Null 0.0295480456086947 -0.12049781
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0295480456086947 0.21102547
NSC 755465 Null 0.0295480456086947 -0.1033385
NSC 87500 Solacongestidine 0.0295480456086947 0.35103841
NSC 93354 Null 0.0295480456086947 -0.03879923
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0314734733353265 0.10011194
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0314734733353265 -0.017518481
NSC 380721 Eremantholide B 0.0314734733353265 -0.02075862
Total:35  Current:24    [First] [Prev] [Next] [Last]